These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19409936)

  • 1. Peripheral mechanisms in the control of appetite and related experimental therapies in obesity.
    Camilleri M
    Regul Pept; 2009 Aug; 156(1-3):24-7. PubMed ID: 19409936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal GLP-1 and satiation: from man to rodents and back.
    Steinert RE; Beglinger C; Langhans W
    Int J Obes (Lond); 2016 Feb; 40(2):198-205. PubMed ID: 26315842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal satiety signals in humans--physiologic roles for GLP-1 and PYY?
    Beglinger C; Degen L
    Physiol Behav; 2006 Nov; 89(4):460-4. PubMed ID: 16828127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut hormones as peripheral anti obesity targets.
    Small CJ; Bloom SR
    Curr Drug Targets CNS Neurol Disord; 2004 Oct; 3(5):379-88. PubMed ID: 15544446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal glucagon-like peptide-1 effects on food intake: Physiological relevance and emerging mechanisms.
    Krieger JP
    Peptides; 2020 Sep; 131():170342. PubMed ID: 32522585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the stomach in the control of appetite and the secretion of satiation peptides.
    Steinert RE; Meyer-Gerspach AC; Beglinger C
    Am J Physiol Endocrinol Metab; 2012 Mar; 302(6):E666-73. PubMed ID: 22215654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications.
    Madsbad S
    Diabetes Obes Metab; 2014 Jan; 16(1):9-21. PubMed ID: 23617798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycoprotein reduces energy intake and postprandial insulin release without altering glucagon-like peptide-1 and peptide tyrosine-tyrosine concentrations in healthy overweight and obese adults: a randomised-controlled trial.
    Bottin JH; Swann JR; Cropp E; Chambers ES; Ford HE; Ghatei MA; Frost GS
    Br J Nutr; 2016 Jul; 116(2):360-74. PubMed ID: 27198187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut hormones and appetite regulation.
    Hong SH; Choi KM
    Curr Opin Endocrinol Diabetes Obes; 2024 Jun; 31(3):115-121. PubMed ID: 38511400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whey Proteins Reduce Appetite, Stimulate Anorexigenic Gastrointestinal Peptides and Improve Glucometabolic Homeostasis in Young Obese Women.
    Rigamonti AE; Leoncini R; Casnici C; Marelli O; Col A; Tamini S; Lucchetti E; Cicolini S; Abbruzzese L; Cella SG; Sartorio A
    Nutrients; 2019 Jan; 11(2):. PubMed ID: 30678029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapies for inter-relating diabetes and obesity - GLP-1 and obesity.
    Iepsen EW; Torekov SS; Holst JJ
    Expert Opin Pharmacother; 2014 Dec; 15(17):2487-500. PubMed ID: 25260877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New physiological effects of the incretin hormones GLP-1 and GIP.
    Asmar M
    Dan Med Bull; 2011 Feb; 58(2):B4248. PubMed ID: 21299928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appetite, Glycemia, and Entero-Insular Hormone Responses Differ Between Oral, Gastric-Remnant, and Duodenal Administration of a Mixed-Meal Test After Roux-en-Y Gastric Bypass.
    Gero D; Steinert RE; Hosa H; Cummings DE; Bueter M
    Diabetes Care; 2018 Jun; 41(6):1295-1298. PubMed ID: 29636353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.
    le Roux CW; Aylwin SJ; Batterham RL; Borg CM; Coyle F; Prasad V; Shurey S; Ghatei MA; Patel AG; Bloom SR
    Ann Surg; 2006 Jan; 243(1):108-14. PubMed ID: 16371744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut hormones ghrelin, PYY, and GLP-1 in the regulation of energy balance [corrected] and metabolism.
    Perez-Tilve D; Nogueiras R; Mallo F; Benoit SC; Tschoep M
    Endocrine; 2006 Feb; 29(1):61-71. PubMed ID: 16622293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The satiety hormone peptide YY as a regulator of appetite.
    Vincent RP; le Roux CW
    J Clin Pathol; 2008 May; 61(5):548-52. PubMed ID: 18441153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
    Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
    Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Glucagon-Like Peptide-1 in Energy Homeostasis.
    Salehi M; Purnell JQ
    Metab Syndr Relat Disord; 2019 May; 17(4):183-191. PubMed ID: 30720393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine control of food intake.
    Valassi E; Scacchi M; Cavagnini F
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):158-68. PubMed ID: 18061414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The multiple faces of glucagon-like peptide-1--obesity, appetite, and stress: what is next? A review.
    Frezza EE; Wachtel MS; Chiriva-Internati M
    Dig Dis Sci; 2007 Mar; 52(3):643-9. PubMed ID: 17268838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.